Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Chinese researchers report that synthetic calcium antagonist improves memory dysfunction

Nov. 5, 1998

Angiotech study of micellar paclitaxel in MS well under way

Nov. 5, 1998

Bayer announces setback in AD drug development

Nov. 5, 1998

New sigma-receptor ligands presented by Sumitomo

Nov. 5, 1998

GlyT-1 technology forms the basis of Allelix and Janssen neuropsychiatric collaboration

Nov. 4, 1998

Meiji Seika discloses new neuroprotective substance isolated from fungus

Nov. 4, 1998

Novel isoquinoline anticonvulsants in development at SB

Nov. 4, 1998

Entropin concentrates its efforts on bringing Esterom to market

Nov. 4, 1998

Monoamine reuptake inhibitors especially useful for Parkinson's disease

Nov. 3, 1998

Positive CPMP opinion issued for Betaseron in new indication

Nov. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...